Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ibrahim, Güllü"'
Autor:
İbrahim Güllü, Ali Övgün
In this paper, we derive an exact black hole spacetime metric in the Einstein-Hilbert-Bumblebee (EHB) gravity around global monopole field. We study the horizon, temperature, and the photon sphere of the black hole. Using the null geodesics equation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a2abf0e27733c38b0ab0144ef2d500e
http://arxiv.org/abs/2012.02611
http://arxiv.org/abs/2012.02611
Publikováno v:
Volume: 9, Issue: 2 178-191
Clinical and Experimental Health Sciences
Clinical and Experimental Health Sciences
Objective: Capecitabine, a prodrug of 5-fluorouracil, is currently used in the treatment of metastatic colorectal and breast cancers. The aim of this study was to review the pharmacological mechanisms, treatment strategies, and documented case report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7e67a119e347ca555b8e041a07bfde
https://dergipark.org.tr/tr/pub/clinexphealthsci/issue/46426/563930
https://dergipark.org.tr/tr/pub/clinexphealthsci/issue/46426/563930
Autor:
Cagatay, Arslan, Sercan, Aksoy, Omer, Dizdar, Mevlut, Kurt, Nilüfer, Güler, Yavuz, Ozisik, Ibrahim, Güllü, Kadri, Altundag
Publikováno v:
Tumori Journal. 97:711-716
Aims and Background Capecitabine, as all fluoropyrimidines, interferes with vitamin metabolism and may thus have an impact on hematopoiesis. It is metabolized to its active form 5-fluoruracil by the enzyme thymidine phosphorylase, which exists in hig
Autor:
Mehmet Akif, Oztürk, Ibrahim, Barişta, M Kadri, Altundağ, Alev, Türker, Suayib, Yalçin, Ismail, Celik, Ibrahim, Güllü, Nilüfer, Güler, Yavuz, Ozişik, Ayşe, Kars, Emin, Kansu, Eşmen, Baltali, Gülten, Tekuzman
Publikováno v:
Chemotherapy. 48(5)
We have evaluated the clinical efficacy and toxicity of a modified etoposide, methylprednisolone, cytarabine and cisplatin (ESHAP) chemotherapy regimen that has been used by the Hacettepe University Department of Medical Oncology (Ankara, Turkey) sin
Autor:
Ibrahim Güllü, Şuayib Yalçin, GÜLten Tekuzman, Ibrahim Barişlta, Necati Alkiş, Ismail Çelik, Nurullah Zengin, NilÜFer Güler, AyŞE Kars, EŞMen Baltali, Emin Kansu, DinÇEr Firat
Publikováno v:
Scopus-Elsevier
Twenty patients with advanced sarcomas entered a pilot study with ifosfamide (IF) and mercaptoethane sulfonate sodium (Mesna) as a second-line treatment for six planned cycles. All patients had received prior doxorubicin- and cyclophosphamide-based c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d4b7d00df0e50470748b9d20e22457
http://www.scopus.com/inward/record.url?eid=2-s2.0-9444298411&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-9444298411&partnerID=MN8TOARS
Publikováno v:
American Journal of Hematology; Nov2005, Vol. 80 Issue 3, p213-215, 0p